Related Experiment Videos
[MRI-guided stereotactic biopsy for questionable diseases in brain]
Yu-qing Zhang1, Guo-guang Zhao, Kun-cheng Li
1Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital University of Medical Sciences, Beijing 100053, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|December 19, 2003
Summary
Magnetic resonance imaging (MRI)-guided stereotactic biopsy accurately diagnoses atypical brain diseases. This method offers reliable diagnosis and treatment for challenging brain lesions, proving superior to CT-guided biopsies.
Area of Science:
- Neurology
- Radiology
- Pathology
Context:
- Brain biopsies are crucial for diagnosing atypical neurological conditions.
- Conventional imaging like CT may fail to detect or characterize certain brain lesions.
- Stereotactic biopsy offers a minimally invasive approach for tissue sampling.
Purpose:
- To evaluate the diagnostic accuracy and clinical utility of MRI-guided stereotactic biopsy for atypical brain diseases.
- To compare the efficacy of MRI-guided versus CT-guided stereotactic biopsy.
- To assess the safety profile of MRI-guided stereotactic biopsy.
Summary:
- Twenty-six patients with atypical or CT-undetectable brain lesions underwent MRI-guided stereotactic biopsy using a CRW stereotactic frame.
- The procedure yielded definite pathological diagnoses for conditions including gliomatosis cerebri, brain cysticercosis, and Krabbe's disease.
- No serious complications such as intracranial hematoma or paralysis were observed.
Impact:
- MRI-guided stereotactic biopsy demonstrates higher accuracy for pathological diagnosis compared to CT-guided methods.
- This technique provides reliable diagnostic information, guiding appropriate treatment for ambiguous brain lesions.
- It enhances patient management by enabling timely and precise interventions for complex neurological cases.